References
- Smith PL. (1997). Peptide delivery via the pulmonary route: a valid approach for local and systemic delivery. J Contr Rel, 46, 99–106.
- Bosquillon C, Préat V, Vanbever R. (2004). Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats. J Contr Rel, 96, 233–44.
- Shoyele SA, Cawthorne S. (2006). Particle engineering techniques for inhaled biopharmaceuticals. Adv Drug Deliv Rev, 58, 1009–29.
- Byron PR. (1990). Determinants of drug and polypeptide bioavailability from aerosols delivered to the lung. Adv Drug Deliv Rev, 5, 107–32.
- Grenha A, Seijo B, Remuñán-López C. (2005). Microencapsulated chitosan nanoparticles for lung protein delivery. Eur J Pharm Sci, 25, 427–37.
- Broadhead J, Edmond-Rouan SK, Rhodes CT. (1992). The spray drying of pharmaceuticals. Drug Dev Ind Pharm, 18, 1169–206.
- Bosquillon C, Lombry C, Préat V, Vanbever R. (2001). Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J Contr Rel, 70, 329–39.
- Johnson KA. (1997). Preparation of peptide and protein powders for inhalation. Adv Drug Deliv Rev, 26, 3–15.
- Irngartinger M, Camuglia V, Damm M, Goedea J, Frijlink HW. (2004). Pulmonary delivery of therapeutic peptides via dry powder inhalation: effects of micronisation and manufacturing. Eur J Pharm Biopharm, 58, 7–14.
- Niven RW, Lott FD, Ip AY, Cribbs JM. (1994). Pulmonary delivery of powders and solutions containing recombinant human granulocyte colony-stimulating factor. Pharm Res, 11, 1101–9.
- Skyler, SJ, Cefalu WT, Kourides IA, Landschulz WH, Balagtas CC, Cheng SL, Gelfand RA. (2001). Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomized proof-concept study. Lancet, 357, 331–5.
- Ventura CA, Tommasini S, Crupi E, Giannone I, Cardilec V, Musumecib T, Puglisi G. (2008). Chitosan microspheres for intrapulmonary administration of moxifloxacin-Interaction with biomembrane models and in vitro permeation studies. Eur J Pharm Biopharm, 68, 235–44.
- Alpar HO, Somavarapu S, Atuah KN, Bramwell VW. (2005). Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Adv Drug Deliv Rev, 57, 411–30.
- Yamamoto H, Kuno Y, Sugimoto S, Takeuchi H, Kawashima Y. (2005). Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J Contr Rel, 102, 373–81.
- Vasir JK, Tambwekar K, Garg S. (2003). Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm, 255, 13–32.
- Griese M, Reinhardt D. (1998). Smaller sized particles are preferentially taken up by alveolar type II pneumocytes. J Drug Target, 5, 471–9.
- Dickinson PA, Howells SW, Kellaway IW. (2001). Novel nanoparticles for pulmonary drug administration. J Drug Target, 9, 295–302.
- Clark A. (2002). Formulation of proteins and peptides for inhalation. Drug Deliv Syst Sci, 2, 73–7.
- Makino K, Yamamoto N, Higuchi K, Harada N, Ohshima H, Terada H. (2003). Phagocytic uptake of polystyrene microspheres by alveolar macrophages: effects of the size and surface properties of the microspheres. Colloids Surf B Biointerf, 27, 33–9.
- Chen L, Zhang Q, Yang G, Fan L, Tang J, Garrard I, Ignatova S, Fisher D, Sutherland IA. (2007). Rapid purification and scale-up of honokiol and magnolol using high-capacity high-speed counter-current chromatography. J Chromatography A, 1142, 115–22.
- Gou ML, Li XY, Dai M, Wang XH, Gong CY, Deng HX, Xie Y, Wang K, Zhao X, Qian ZY, Wei YQ. (2008). A novel injectable local hydrophobic drug delivery system: biodegradable nanoparticles in thermo-sensitive hydrogel. Int J Pharm, 359, 228–33.
- Rattes ALR, Oliveira WP. (2007). Spray drying conditions and encapsulating composition effects on formation and properties of sodium diclofenac microparticles. Powder Technol, 171, 7–14.
- De Villiers MM. (2005). Powder flow and compressibility. In: Ghosh TK, Jasti BR, eds. Theory and Practice of Contemporary Pharmaceutics. Boca Raton, FL: CRC Press, 298–9.
- Learoyd TP, Burrows JL, French E, Seville PC. (2008). Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate. Eur J Pharm Biopharm, 68, 224–34.
- Chan HK. (2006). Dry powder aerosol drug delivery-opportunities for colloid and surface scientists. Colloids Surf A Physicochem Eng Aspects, 284–5, 50–5.